![Colin Scott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Colin Scott was Vice President of Clinical Research and Development for NovaBay Pharmaceuticals, Inc. from January 2006 to December 31, 2008.
From October 2004 to December 2005, he was Vice President-Drug Development for GlycoMimetics.
From June 2004 to September 2004, Dr. Scott was a Consultant to several biopharmaceutical companies.
From September 2002 to May 2004, he served as the Vice President-Clinical and Regulatory at Arriva Pharmaceuticals, Inc. From March 2001 to May 2002, Dr. Scott served as Vice President-Clinical of Emisphere Technologies, Inc. He received a Medical degree in Pulmonology and Infectious Diseases from Glasgow University in Scotland.
Eerdere bekende functies van Colin Scott
| Bedrijven | Functie | Einde |
|---|---|---|
| STABLECOIN DEVELOPMENT CORPORATION | Hoofd Techniek/Wetenschap/O&O | 31-12-2008 |
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Corporate Officer/Principal | 01-12-2005 |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Hoofd Techniek/Wetenschap/O&O | 01-05-2004 |
| EMISPHERE TECHNOLOGIES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2002 |
Opleiding van Colin Scott
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Health Technology |
NovaBay Pharmaceuticals, Inc.
 NovaBay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and sale of eye and wound care products | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
